GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (FRA:01P) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Medpace Holdings (FRA:01P) Future 3-5Y EPS without NRI Growth Rate : 7.42 (As of Apr. 14, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Medpace Holdings Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Medpace Holdings's Future 3-5Y EPS without NRI Growth Rate is 7.42.

Competitive Comparison of Medpace Holdings's Future 3-5Y EPS without NRI Growth Rate

For the Diagnostics & Research subindustry, Medpace Holdings's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medpace Holdings's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Medpace Holdings's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Medpace Holdings's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Medpace Holdings  (FRA:01P) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Medpace Holdings Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Medpace Holdings's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Medpace Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Medpace Holdings Inc (FRA:01P) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
QGEN EXAS CRL ILMN RVTY GH ICLR RDNT SHC WGS TMO DHR XSWX:LONN IDXX A IQV SHSE:603259 MTD WAT NTRA
Traded in Other Exchanges
MEDP:USA
Address
5375 Medpace Way, Cincinnati, OH, USA, 45227
Website
https://www.medpace.com
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Medpace Holdings Headlines

No Headlines